Document is current
Any future updates will be listed below
-
Authors
Cong, Anh T. Q. https://orcid.org/0000-0001-9307-7741
Witter, Taylor L. https://orcid.org/0000-0003-3096-3011
Bruinsma, Elizabeth S.
Sarkar Bhattacharya, Sayantani https://orcid.org/0000-0001-8971-7566
Jayaraman, Swaathi https://orcid.org/0000-0002-5451-0052
Wyatt, Samuel R.
Solverson, Jasper K. https://orcid.org/0000-0001-5801-821X
Dugan, Maria B. https://orcid.org/0000-0001-5862-6637
Paluncic, Jasmina https://orcid.org/0000-0003-3420-1532
Kuffel, Mary J.
Alvey, Julia R. https://orcid.org/0000-0001-6549-9816
Huynh, Huy V. https://orcid.org/0009-0007-9304-8087
Wu, Xinyan
Fields, Alan P. https://orcid.org/0000-0001-9529-0888
Pandey, Akhilesh https://orcid.org/0000-0001-9943-6127
Hawse, John R. https://orcid.org/0000-0003-3406-470X
Goetz, Matthew P. https://orcid.org/0000-0002-4383-270X
Schellenberg, Matthew J. https://orcid.org/0000-0001-7036-5943
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (P50CA116201)
- License Information
-
More Information
Article History
Received: 6 June 2024
Accepted: 12 May 2026
First Online: 21 May 2026
Competing interests
: M.P.G. reports personal fees for CME activities from AXIS, BroadcastMed, DAVA Oncology, IDEOlogy Health, MJH Life Sciences, PeerView, Physicians’ Education Resource, Research to Practice, and Total Health Conferencing; consulting fees to Mayo Clinic from AstraZeneca, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Ltd., Ataraxis AI, BeiGene USA, Biotheranostics, Biotheryx, eChinaHealth, EcoR1, Eli Lilly and Company, Engage Health Media, Genentech, Incyclix, Lilly, Laekna, Novartis, Pfizer, Puma, RNA Diagnostics, Seattle Genetics, Sermonix Pharmaceuticals, Stemline Therapeutics, and TerSera Therapeutics/Amplity Health; grant funding to Mayo Clinic from AstraZeneca, ATOSSA Therapeutics, Biotheryx, Lilly, Loxo, Pfizer, Sermonix, and SimBioSys; travel support from Lilly. The remaining authors declare no competing interests.
